FutureFemHealth

FutureFemHealth

Home
Work with us / Advertise
CensHERship
FutureFemHealth Pro
Partners and contributors
Archive
About
New white paper makes the business case for teaching every doctor about menopause
With just 6.8% of residents feeling prepared to manage menopause, the new white paper argues the knowledge gap needs to be tackled before doctors…
 • Anna O'Sullivan
Aitiologic raises €6.4m seed to advance preeclampsia risk test
Vienna-based precision medicine company is developing technology to identify preeclampsia risk from the same first-trimester blood sample already used…
 • Anna O'Sullivan
Evvy raises $40m Series B to take its vaginal microbiome platform further into women’s health
CEO Priyanka Jain tells FutureFemHealth why Evvy is expanding into new areas of women’s health
 • Anna O'Sullivan
Wisp expands into broader women’s health platform after reaching 2m patients
New CEO appointed for next phase of growth
 • Anna O'Sullivan
What if the next women’s health diagnostic doesn’t require another test?
A new use for mammography is the latest example of a strategy gaining commercial traction across women’s health: getting more health information from…
 • Anna O'Sullivan
Viv raises $2m to expand period care brand and launch new tampon technology
Patented tampon design developed to prevent cotton fibres being left behind in body
 • Anna O'Sullivan
Issue 162: Mainstream bank launches women’s health fund | €15m pregnancy diagnostics raise | inhaled IVF drugs
+ lots more in the weekly briefing on the global women's health market
 • Anna O'Sullivan
Femtech France launches Europe-wide women’s health innovation forum
First Forum taking place in Paris this November
 • Anna O'Sullivan
💌 Issue 161: $35m for preeclampsia | new heart attack guidance | Flo’s IPO signal | birth injury investment
+ lots more in the weekly briefing on the global women's health market
 • Anna O'Sullivan
Phira emerges from stealth with earring wearable to track hormone patterns
The US startup is using physiological signals from behind the ear to follow changes associated with estrogen, LH and progesterone across the menstrual…
 • Anna O'Sullivan
Flo Health hires IPO-experienced CMO as it enters next phase of growth
Rina Hahn helped scale Remitly through its IPO, experience Flo says demonstrates the capabilities it needs for its next phase.
 • Anna O'Sullivan
Is maternal birth injury prevention becoming an investable category?
New funding for Peripear and Materna Medical suggests investors are looking upstream at a common but overlooked problem.
 • Anna O'Sullivan
© 2026 FutureFemHealth Ltd · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture